Chronic kidney disease and cardiovascular risk: Pathophysiology and interventional approaches - systematic review

慢性肾脏病与心血管风险:病理生理学和干预方法——系统评价

阅读:1

Abstract

BACKGROUND: Chronic kidney disease (CKD) is a major public health concern due to its association with increased cardiovascular risk. Patients with CKD, especially those with moderate to severe renal dysfunction, face a heightened risk of cardiovascular events and mortality. This systematic review evaluates the relationship between CKD and cardiovascular risk, focusing on the pathophysiology, risk factors, and clinical outcomes related to cardiovascular disease (CVD) in CKD populations. METHODS: A comprehensive search of electronic databases was conducted for studies investigating CKD and cardiovascular risk. Seven studies, including cross-sectional, and cohort designs, were included in this review. These studies involved a total of 104,576 participants, with diverse stages of CKD and varying cardiovascular risk profiles. Data on renal dysfunction stages, cardiovascular risk factors, and mortality outcomes were extracted and analyzed. RESULTS: The studies consistently demonstrated that CKD is associated with an increased risk of cardiovascular events, including coronary heart disease and stroke, compared to individuals without CKD. Even early stages of CKD were linked to a higher likelihood of CVD. Participants with CKD exhibited a greater burden of traditional cardiovascular risk factors, including hypertension, diabetes, dyslipidemia, and obesity. The overall mortality rate from cardiovascular causes was also higher in CKD patients, with some studies reporting a two-fold or greater increase in risk. CONCLUSION: CKD is strongly linked to an increased cardiovascular risk, with higher stages of renal dysfunction associated with a more significant risk of cardiovascular morbidity and mortality. This review emphasizes the need for early detection and comprehensive management of cardiovascular risk factors in CKD patients. Future research should focus on identifying novel biomarkers and evaluating the long-term efficacy of emerging therapies in reducing cardiovascular risk in CKD populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。